Cryptococcal antigenemia in immunocompromised human immunodeficiency virus patients in rural Tanzania: A preventable cause of early mortality

Keyphrases

• Cryptococcal Antigen 100%
• Early Mortality 100%
• Preventable Causes 100%
• Cryptococcal Antigenemia 100%
• Rural Tanzania 100%
• Human Immunodeficiency Virus Patients 100%
• Antiretroviral Therapy 80%
• Antigen Screening 60%
• Treatment-naïve 40%
• Fluconazole 40%
• AIDS/HIV 20%
• Cryptococcal Meningitis 20%
• Mortality Prediction 20%
• Meningitis 20%
• Odds Ratio 20%
• World Health Organization 20%
• Leading Causes of Death 20%
• Improved Survival 20%
• High Threshold 20%
• CD41 20%
• Southern Tanzania 20%
• Human Immunodeficiency Virus/acquired Immunodeficiency Syndrome 20%
• People Living with Human Immunodeficiency Virus 20%
• Retention in Care 20%

Medicine and Dentistry

• Human Immunodeficiency Virus 100%
• Fluconazole 66%
• Meningitis 33%
• Prevalence 33%
• Cryptococcal Meningitis 33%
• Retrospective Study 33%
• Acquired Immune Deficiency Syndrome 33%
• Odds Ratio 33%

Pharmacology, Toxicology and Pharmaceutical Science

• HIV 100%
• Fluconazole 66%
• Retrospective Study 33%
• Prevalence 33%
• Cryptococcal Meningitis 33%
• Meningitis 33%
• Acquired Immune Deficiency Syndrome 33%